Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Paola Tacchetti, Gianpietro Semenzato, Francesca Patriarca et al.|The Lancet Haematology|2020

Cited by 58